Sarpogrelate hydrochloride tablets 50mg “Sawai” from Sawai Pharmaceutical contain Sarpogrelate hydrochloride. This medication, a selective 5-HT2A receptor antagonist, works to improve blood flow by inhibiting platelet aggregation and vasoconstriction, and is used for ischemic symptoms related to chronic arterial occlusion. The standard is 50mg per tablet (YJ code: 3399006F1182).
Sarpogrelate hydrochloride tablets 50mg “Sawai”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →More with the same ingredient
